GIPAM

GIPAM is a Munich-based digital health consultancy focused on elevating market access and RWE services through a combination of strategic expertise, proprietary technology, and data. Its core offering, the 'GIPAM way,' guarantees project timelines and budgets while emphasizing scientifically sound, publishable research using advanced methodologies. The company serves a global clientele, primarily in the pharmaceutical sector, helping them demonstrate product value from clinical development through post-approval commercialization.

Proprietary digital tools including 'EVIGATOR' for study feasibility and checklists, and 'GIPAM Study Reporting (GSR)' for live, daily-updated client dashboards. Leverages AI/ML for data analysis and utilizes advanced statistical methodologies (e.g., inverse-probability weighting, cluster analysis) on real-world data from claims and registries.

GIPAM competes with large, full-service CROs (e.g., IQVIA, Parexel) that have massive RWE divisions, as well as specialized HEOR and market access consultancies (e.g., Evidera, PHMR, Cytel). Its differentiation is based on its 'GIPAM way' guarantees, proprietary technology for transparency (GSR), and a strategic, rather than transactional, client partnership model.